Susanne Olausson

Susanne Olausson, listed as board member, has filed trades across 2 companies (mainly through Finansinspektionen), most often in Redsense Medical AB (publ) and Odinwell AB. We count 12 filings; the first trade dates from 2 March 2018 and the latest from 10 September 2026.

Both buying and selling appear: 11 purchases worth €85k, against 1 sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €6,086. Measured against the company's value, the median purchase equals 0.15% of market capitalisation, across 4 purchases where it is known. On 2 out of 10 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 11 September 2026, the filings show an open-market purchase worth €6,105 in Redsense Medical AB (publ). Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.